2015
$250M
from 6 investors over 6 rounds
Emendo Biotherapeutics raised $250M on December 15, 2020
Investors: Anges MG, Inc
Emendo Biotherapeutics raised $61M on January 15, 2020
Investors: Anges MG, Inc, OrbiMed Advisors and Takeda UK Limited
Emendo Biotherapeutics raised $6.8M on September 29, 2016
Investors: Takeda UK Limited and OrbiMed Advisors